Table 2.

Association results in the Icelandic population for 7 markers previously reported to have suggestive association with lung cancer.

SNP(allele)	CHR	cases (N)	cases (F)	cont. (N)	cont. (F)	OR	95%CI	P	OR*
rs4254535(T)	2p14	1,452	0.672	36203	0.68	0.97	0.89-1.05	0.45	0.89
rs1530057(A)	3p24.1	1,429	0.049	36224	0.048	1.01	0.83-1.23	0.93	1.26
rs6438347(G)	3q13.31	1,454	0.209	36259	0.223	0.92	0.83-1.02	0.10	0.88
rs1926203(T)	10q23.31	1,466	0.671	36273	0.674	0.99	0.90-1.08	0.76	1.12
rs504417(G)	15q15.2	1,447	0.275	36228	0.301	0.88	0.80-0.96	0.0043	0.89
rs11853991(G)	15q15.2	1,451	0.274	36246	0.301	0.88	0.80-0.96	0.0036	0.89
rs748404(T)	15q15.2	1,447	0.825	36256	0.797	1.20	1.08-1.33	0.00052	1.15

Shown are the SNP name, allele tested, chromosome location, the number of individuals (N) and the allelic frequency (F) of the variant in cases and controls, allelic odds-ratio (OR), 95% CI and P values based on the multiplicative model and the OR reported by Broderick et al. (OR*). All P values are two-sided.